These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27776387)

  • 1. Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks Follow-up Study on Efficacy and Tolerability.
    Akpınar E; Cerit C; Talas A; Tural Ü
    Clin Psychopharmacol Neurosci; 2016 Nov; 14(4):351-356. PubMed ID: 27776387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline versus escitalopram in South Asians with moderate to severe major depressive disorder: (SOUTH-DEP) a double-blind, parallel, randomized controlled trial.
    Raza S; Ahmed S; Islam R; Ahmed M; Ashraf S; Islam H; Kiyani H; Saqib M; Shah SAR; Mumtaz H
    Ann Med Surg (Lond); 2023 Oct; 85(10):4851-4859. PubMed ID: 37811114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine as monotherapy for major depression: an outpatient, open-label study.
    Pecenak J; Novotny V
    Neuropsychiatr Dis Treat; 2013; 9():1595-604. PubMed ID: 24174876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients.
    Forlenza OV; Stoppe Júnior A; Hirata ES; Ferreira RC
    Sao Paulo Med J; 2000 Jul; 118(4):99-104. PubMed ID: 10887385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline effectiveness and safety in depressed oncological patients.
    Torta R; Siri I; Caldera P
    Support Care Cancer; 2008 Jan; 16(1):83-91. PubMed ID: 17874143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.
    Komaram RB; Nukala S; Palla J; Nambaru LR; Kasturi SM
    J Clin Diagn Res; 2015 Jun; 9(6):VC05-VC08. PubMed ID: 26266196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.
    Karaiskos D; Tzavellas E; Ilias I; Liappas I; Paparrigopoulos T
    Int J Clin Pract; 2013 Mar; 67(3):257-60. PubMed ID: 23409693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting.
    Andrade C
    Indian J Psychiatry; 2011 Jan; 53(1):69-72. PubMed ID: 21431013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder.
    Bisserbe J; Lane R; Flament M;
    Eur Psychiatry; 1997; 12(2):82-93. PubMed ID: 19698511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder].
    Ushkalova AV; Kostyukova EG; Mosolov SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1 Pt 2):23-30. PubMed ID: 25909803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression.
    Lalit V; Appaya PM; Hegde RP; Mital AK; Mittal S; Nagpal R; Palaniappun V; Ramsubramaniam C; Rao GP; Roy K; Trivedi JK; Vankar GK; Karan RS; Shah S; Patel RB
    Indian J Psychiatry; 2004 Oct; 46(4):333-41. PubMed ID: 21206792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study.
    Urade CS; Mahakalkar SM; Tiple PG
    J Pharmacol Pharmacother; 2015; 6(4):198-203. PubMed ID: 26813706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients.
    SESS Group (Sertraline Efficacy and Safety Study Group)
    J Med Assoc Thai; 2001 Jan; 84(1):54-62. PubMed ID: 11281500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.